SVP, Controller, CAO Daniel Bazarko sold $3.8M of Alexion Pharmaceuticals, Inc.

Sold$3,795,233

$157.70Price

24,066Shares

−44%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Thu, Dec 17. Filed Mon, Dec 21, 12:00 PM ET, during the session. Not investment advice.